GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $2.30 $2.95 Thursday, 18th Apr 2024 CLLS stock ended at $2.47. This is 0.407% more than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 14.35% from a day low at $2.30 to a day high of $2.63.
90 days $2.30 $3.13
52 weeks $0.96 $3.77

Historical Cellectis S.A. prices

Date Open High Low Close Volume
2024-04-18 $2.53 $2.63 $2.30 $2.47 14 879
2024-04-17 $2.57 $2.57 $2.45 $2.46 6 891
2024-04-16 $2.50 $2.65 $2.49 $2.49 84 185
2024-04-15 $2.59 $2.65 $2.54 $2.61 41 884
2024-04-12 $2.80 $2.80 $2.67 $2.69 60 016
2024-04-11 $2.81 $2.86 $2.78 $2.80 14 726
2024-04-10 $2.66 $2.81 $2.66 $2.79 10 825
2024-04-09 $2.82 $2.82 $2.70 $2.75 20 306
2024-04-08 $2.69 $2.89 $2.60 $2.69 81 435
2024-04-05 $2.70 $2.74 $2.66 $2.68 12 922
2024-04-04 $2.76 $2.89 $2.72 $2.75 21 287
2024-04-03 $2.80 $2.95 $2.66 $2.79 45 942
2024-04-02 $2.66 $2.69 $2.56 $2.65 36 287
2024-04-01 $2.61 $2.64 $2.41 $2.54 42 483
2024-03-28 $2.71 $2.75 $2.65 $2.65 44 042
2024-03-27 $2.56 $2.71 $2.50 $2.67 7 359
2024-03-26 $2.55 $2.60 $2.43 $2.57 35 396
2024-03-25 $2.38 $2.58 $2.38 $2.58 28 132
2024-03-22 $2.52 $2.53 $2.42 $2.50 20 854
2024-03-21 $2.41 $2.55 $2.41 $2.53 15 280
2024-03-20 $2.41 $2.45 $2.35 $2.45 17 012
2024-03-19 $2.38 $2.47 $2.38 $2.41 25 662
2024-03-18 $2.56 $2.56 $2.43 $2.49 24 603
2024-03-15 $2.65 $2.65 $2.43 $2.54 33 134
2024-03-14 $2.64 $2.67 $2.47 $2.53 17 809
Click to get the best stock tips daily for free!

About Cellectis S.A.

Cellectis S.A. Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL... CLLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT